Invention Grant
US07884091B2 Methods for treating delirium using glucocorticoid receptor-specific antagonists
有权
使用糖皮质激素受体特异性拮抗剂治疗del妄的方法
- Patent Title: Methods for treating delirium using glucocorticoid receptor-specific antagonists
- Patent Title (中): 使用糖皮质激素受体特异性拮抗剂治疗del妄的方法
-
Application No.: US11383017Application Date: 2006-05-12
-
Publication No.: US07884091B2Publication Date: 2011-02-08
- Inventor: Joseph K. Belanoff
- Applicant: Joseph K. Belanoff
- Applicant Address: US DE
- Assignee: Corcept Therapeutics, Inc.
- Current Assignee: Corcept Therapeutics, Inc.
- Current Assignee Address: US DE
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K31/56
- IPC: A61K31/56
Abstract:
This invention generally pertains to the field of psychiatry. In particular, this invention pertains to the discovery that agents which inhibit the binding of cortisol to its receptors can be used in methods for treating delirium. Mifepristone, a potent specific glucocorticoid receptor antagonist, can be used in these methods. The invention also provides a kit for treating delirium in a human including a glucocorticoid receptor antagonist and instructional material teaching the indications, dosage and schedule of administration of the glucocorticoid receptor antagonist.
Public/Granted literature
- US20060194713A1 METHODS FOR TREATING DELIRIUM USING GLUCOCORTICOID RECEPTOR-SPECIFIC ANTAGONISTS Public/Granted day:2006-08-31
Information query
